Literature DB >> 19328395

Obstructive acute renal failure related to amantadine intoxication.

Kentaro Nakai1, Kazuhito Takeda, Hiroshi Kimura, Shuhei Miura, Atsuhiro Maeda.   

Abstract

We report the case of a 69-year-old woman with seizures and acute renal failure with hyperkalemia. She presented with bladder turgescence and hydronephrosis on admission and was diagnosed as obstructive acute renal failure. Urethral catheterization was performed after a single-session hemodialysis. It resulted in immediate improvement of renal function and consciousness, and subsequent disappearance of seizures. Improvement of serum creatinine level to 0.7 from 10.6 mg/dL was associated with a fall in blood level of amantadine hydrochloride from 4.40 to 0.47 microg/mL. Physicians should be aware of urinary retention in patients treated with amantadine as a first sign of intoxication that could lead if untreated to obstructive acute renal failure. And we recommend to check the overdose symptoms, even those with normal renal function, treated with amantadine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19328395     DOI: 10.1016/j.ajem.2008.07.020

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  4 in total

1.  Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy.

Authors:  Saskia Müller-Rebstein; Claudia Trenkwalder; Jens Ebentheuer; Wolfgang H Oertel; Carsten Culmsee; Günter U Höglinger
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

2.  Case Reports Describing Amantadine Intoxication in a Rehabilitation Hospital.

Authors:  Kenjiro Kunieda; Takashi Shigematsu; Ichiro Fujishima
Journal:  Prog Rehabil Med       Date:  2017-12-27

3.  Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets.

Authors:  Tina deVries; Angela Dentiste; Clifford Di Lea; Vincent Pichette; David Jacobs
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

Review 4.  Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses.

Authors:  Aarthi Narayanan; Charles Bailey; Fatah Kashanchi; Kylene Kehn-Hall
Journal:  Expert Opin Investig Drugs       Date:  2011-02       Impact factor: 6.498

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.